Single-Dose IA ropivacaine reduces pain up to 8 hours post arthroscopic knee surgery .
Single-dose intra-articular ropivacaine after arthroscopic knee surgery decreases post-operative pain without increasing side effects: a systematic review and meta-analysis
Knee Surg Sports Traumatol Arthrosc. 2016 May;24(5):1651-98 randomized controlled trials (RCTs), with 567 patients who underwent arthroscopic knee surgery and used either single-dose intra-articular (IA) ropivacaine or a postoperative analgesic for pain management were included in the study. The purpose of this study was to determine the efficacy of intra-articular ropivacaine in providing post-surgery pain management while examining the incidence of side effects and adverse events. The findings of this meta-analysis indicated that single-dose IV ropivacaine significantly reduces pain up to 8 hours postoperatively in comparison to the control group without causing increased complications.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
